Chronic inflammatory disease patients at greater risk of major CV eventsNovember 7, 2014CardiologyDermatologyRheumatology
Control of early RA maintained with reduced-dose etanercept plus methotrexateNovember 5, 2014Rheumatology
Trial backs rituximab for maintenance of ANCA-associated vasculitis remissionNovember 5, 2014Rheumatology
Disease activity, not lipid levels, appear to affect CV risk with tocilizumabOctober 31, 2014CardiologyRheumatology
Brain changes identified in chronic fatigue syndromeOctober 29, 2014Alzheimer's & CognitionPainNeurologyRheumatology
FDA approves new abuse-prevention labeling for extended-release EmbedaOctober 18, 2014Critical CareHospice & Palliative MedicinePainAddiction MedicineNeurologyOncologyRheumatology
